CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Clobetasol Propionate (emollient)

clobetasol propionate· ingredient clobetasolCorticosteroids, plain· CLOBETASOL PROPIONATE .5 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.58990
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 8 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other clobetasol products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
clobetasol propionate$0.11487−$0.47500
Clobetasol Propionate$0.12147−$0.46840
Clobetasol Propionate Cream 0.05% Clobetasol Propionate Cream 0.05%$0.15938−$0.43050
clobetasol propionate$0.17794−$0.41200
Clobex$0.24543−$0.34450
clobetasol propionate$0.32513−$0.26480
CLOBEX$0.33318−$0.25670
Clobex$0.34854−$0.24140

Medicare Part D coverage · CY2026

On 312 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 65% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.